Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"

Saved in:
Bibliographic Details
Published inDermatologic surgery Vol. 50; no. 6; p. 534
Main Author Hausauer, Amelia K
Format Journal Article
LanguageEnglish
Published United States 01.06.2024
Subjects
Botulinum Toxins, Type A - administration & dosage
Botulinum Toxins, Type A - adverse effects
Clinical Trials, Phase III as Topic
Double-Blind Method
Humans
Hypertrophy
Masseter Muscle
Neuromuscular Agents - administration & dosage
Neuromuscular Agents - adverse effects
Randomized Controlled Trials as Topic
Treatment Outcome
Online AccessGet more information

Cover

More Information
ISSN:1524-4725
DOI:10.1097/DSS.0000000000004181